Search Results 341-350 of 16327 for Chronic Lymphocytic Leukemia

  1. Methylation and Chromatin Abnormalities in Myelodysplastic Syndromes and Chronic Myelomonocytic leukemia. - Mayo Clinic

    Methylation and Chromatin Abnormalities in Myelodysplastic Syndromes and Chronic Myelomonocytic leukemia. · Overview · Participation eligibility · Participating ...

  2. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  3. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    History of Richter's transformation of chronic lymphocytic leukemia. Autologous stem cell transplant (SCT) within 6 weeks of planned axicabtagene ciloleucel ...

  4. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Chronic lymphocytic leukemia, Acute lymphocytic leukemia, Acute myelogenous leukemia, Myelodysplastic syndromes, Chroni...c myelogenous leukemia ...

  5. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

    T-cell prolymphocytic leukemia;; T-cell large granular lymphocytic leukemia;; Chronic lymphoproliferative disorder of NK cells;; Aggressive NK-cell leukemia; ...

  6. A Safety Study of SGN-CD19A for Leukemia and Lymphoma - Mayo Clinic

    Pathologically confirmed diagnosis of B-lineage acute lymphoblastic leukemia, Burkitt leukemia or lymphoma, or B-lineage lymphoblastic lymphoma; Measurable ...

  7. CAR-T Cell Therapy Program - Department home - Mayo Clinic

    CAR -T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia; Relapsed, refractory B-cell non-Hodgkin's lymphoma ...

  8. Chemotherapy Clinical Trials - Mayo Clinic Research

    ... acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  9. Ponatinib (oral route) - Mayo Clinic

    Ponatinib is used to treat chronic phase chronic myeloid leukemia (CML) ... acute lymphoblastic leukemia (Ph+ ALL). It is also used alone in patients ...

  10. Grant Archives — Immunity and Fibrosis Platform - Center for Biomedical Discovery - Mayo Clinic Research

    Central hypothesis: A significant cause of death for patients with chronic lymphocytic leukemia (CLL) is not the cancer itself, but infections due to a damaged ...